-
公开(公告)号:US20230035617A1
公开(公告)日:2023-02-02
申请号:US17755573
申请日:2020-11-10
申请人: Pfizer Inc.
摘要: The present invention relates to the field of pharmaceutical formulations of antibodies. Specifically, the present invention relates to a stable liquid antibody formulation and its pharmaceutical preparation and use. This invention is exemplified by an aqueous formulation of an anti-Tissue Factor Pathway Inhibitor (TFPI) antibody.